Showing results (1331-1340 of 1,568) with videos related to

Sort By:
Pageof 157
The Journal of Surgical Research|July 23, 2013
Palliative and end-of-life care training during the surgical clerkshipKathryn M Tchorz, S Bruce Binder, Mary T White, et al.
Scientific Reports|October 21, 2017
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitorsShin Numao, Franziska Hasler, Claire Laguerre, et al.
Archivos Espanoles De Urologia|October 16, 2018
[Prognostic factors and response predictors in castration resistant prostate cancer.]Juan Ignacio Pascual Piédrola, Mateo Hevia Suárez, Francisco Javier Ancizu Markert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2014
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responsesJames M Markert, Shantanu N Razdan, Hui-Chien Kuo, et al.
Critical Reviews in Clinical Laboratory Sciences|May 19, 2016
Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproductionB P Foster, T Balassa, T D Benen, et al.
Nature Communications|April 24, 2025
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunityUpasana Sahu, Matthew P Mullarkey, Sara A Murphy, et al.
Blood|April 19, 2003
Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patientsM Louise Markert, Marcella Sarzotti, Daniel A Ozaki, et al.
Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.
Molecular Cancer Therapeutics|May 6, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time DependentStacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, et al.
Pageof 157